BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36299233)

  • 21. Detecting Invasive Fungal Disease in Surgical Patients: Utility of the (13)- β-d-Glucan Assay.
    Skubic J; Taghavi S; Castillo-Angeles M; Ramsis R; Salim A; Askari R
    Surg Infect (Larchmt); 2020 Jun; 21(5):461-464. PubMed ID: 31895667
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.
    Giacobbe DR; Del Bono V; Viscoli C; Mikulska M
    Expert Rev Anti Infect Ther; 2017 Dec; 15(12):1101-1112. PubMed ID: 29125373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of a combination of fungal biomarkers for the diagnosis of invasive fungal disease in high-risk haematology patients.
    Hammarström H; Stjärne Aspelund A; Christensson B; Heußel CP; Isaksson J; Kondori N; Larsson L; Markowicz P; Richter J; Wennerås C; Friman V
    Mycoses; 2018 Sep; 61(9):623-632. PubMed ID: 29577474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Performance of (1→3)-β-D-Glucan Alone and in Combination with
    Springer J; Held J; Mengoli C; Schlegel PG; Gamon F; Träger J; Kurzai O; Einsele H; Loeffler J; Eyrich M
    J Fungi (Basel); 2021 Mar; 7(3):. PubMed ID: 33810069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-d-Glucan for Diagnosing
    Mercier T; Guldentops E; Patteet S; Beuselinck K; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30918045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
    Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
    PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance.
    Weinbergerova B; Kabut T; Kocmanova I; Lengerova M; Pospisil Z; Kral Z; Mayer J
    Sci Rep; 2020 Oct; 10(1):17963. PubMed ID: 33087853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of (1-3)-Β-D-Glucan Test in the Diagnosis of Invasive Fungal Infections among High-Risk Patients in a Tertiary Care Hospital.
    Sandhar TK; Chhina DK; Gupta V; Chaudhary J
    J Lab Physicians; 2022 Sep; 14(3):306-311. PubMed ID: 36119434
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: a systematic review with meta-analysis.
    Singh S; Singh M; Verma N; Sharma M; Pradhan P; Chauhan A; Jaiswal N; Chakrabarti A; Singh M
    Med Mycol; 2021 Feb; 59(2):139-148. PubMed ID: 32448907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interpretation, pitfalls of biomarkers in diagnosis of invasive fungal diseases.
    Lass-Florl C; Alastruey-Izquierdo A; Gupta R; Chakroborti A
    Indian J Med Microbiol; 2022; 40(4):480-484. PubMed ID: 35970627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients.
    Levesque E; Rizk F; Noorah Z; Aït-Ammar N; Cordonnier-Jourdin C; El Anbassi S; Bonnal C; Azoulay D; Merle JC; Botterel F
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and outcome of invasive fungal disease in children after hematopoietic cell transplantation or treated for malignancy: Impact of national programme of antifungal prophylaxis.
    Czyżewski K; Gałązka P; Frączkiewicz J; Salamonowicz M; Szmydki-Baran A; Zając-Spychała O; Gryniewicz-Kwiatkowska O; Zalas-Więcek P; Chełmecka-Wiktorczyk L; Irga-Jaworska N; Bień E; Ociepa T; Wawryków P; Tomaszewska R; Płonowski M; Pierlejewski F; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Zaucha-Prażmo A; Goździk J; Chaber R; Gil L; Styczyński J
    Mycoses; 2019 Nov; 62(11):990-998. PubMed ID: 31429997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
    Koo S; Bryar JM; Page JH; Baden LR; Marty FM
    Clin Infect Dis; 2009 Dec; 49(11):1650-9. PubMed ID: 19863452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UTILITY OF OCULAR β- d -GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.
    Xia T; Finkelman M; Kolomeyer A; Ying GS; Bracha P; Miller CG; Elnahry AG; Carroll R; Zhang Y; Saluadades A; Brucker AJ; Kim BJ
    Retin Cases Brief Rep; 2023 Nov; 17(6):676-682. PubMed ID: 35199648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of invasive fungal disease in haematologic patients.
    Souza L; Nouér SA; Morales H; Simões B; Solza C; Queiroz-Telles F; Nucci M
    Mycoses; 2021 Mar; 64(3):252-256. PubMed ID: 33141969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of β-D-glucan in diagnosis of suspected
    Juniper T; Eades CP; Gil E; Fodder H; Quinn K; Morris-Jones S; Gorton RL; Wey EQ; Post FA; Miller RF
    Int J STD AIDS; 2021 Oct; 32(11):1074-1077. PubMed ID: 34106017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.
    Litvintseva AP; Lindsley MD; Gade L; Smith R; Chiller T; Lyons JL; Thakur KT; Zhang SX; Grgurich DE; Kerkering TM; Brandt ME; Park BJ
    Clin Infect Dis; 2014 Mar; 58(5):622-30. PubMed ID: 24336827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
    He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
    J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients.
    Whitehurst DA; Friedman DL; Zhao Z; Sarma A; Snyder E; Dulek DE; Banerjee R; Kitko CL; Esbenshade AJ
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30818. PubMed ID: 38110594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.